−882 KRW
−19.26 B KRW
2.60 B KRW
11.95 M
About GENCURIX INC.
Sector
Industry
CEO
Sang-Rae Cho
Website
Headquarters
Seoul
Founded
2011
ISIN
KR7229000005
FIGI
BBG00B8VFQ59
Gencurix, Inc. is engaged in developing and manufacturing of cancer diagnostic test kits. Its products include GenesWell BCT, GenesWell ddEGFR Mutation Test, GenesWell CDx EGFR Mutation Test, and GenesWell ddEGFR Mutation Test. The company was founded on September 21, 2011 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 229000 is 2,215 KRW — it has increased by 29.93% in the past 24 hours. Watch GENCURIX INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENCURIX INC. stocks are traded under the ticker 229000.
229000 stock has risen by 17.17% compared to the previous week, the month change is a −5.69% fall, over the last year GENCURIX INC. has showed a −62.65% decrease.
229000 reached its all-time high on Jun 25, 2020 with the price of 25,055 KRW, and its all-time low was 1,131 KRW and was reached on Dec 9, 2024. View more price dynamics on 229000 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
229000 stock is 22.98% volatile and has beta coefficient of 1.53. Track GENCURIX INC. stock price on the chart and check out the list of the most volatile stocks — is GENCURIX INC. there?
Today GENCURIX INC. has the market capitalization of 20.02 B, it has decreased by −9.82% over the last week.
Yes, you can track GENCURIX INC. financials in yearly and quarterly reports right on TradingView.
229000 net income for the last quarter is −1.87 B KRW, while the quarter before that showed −4.05 B KRW of net income which accounts for 53.95% change. Track more GENCURIX INC. financial stats to get the full picture.
No, 229000 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 73.00 employees. See our rating of the largest employees — is GENCURIX INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENCURIX INC. EBITDA is −9.79 B KRW, and current EBITDA margin is −422.45%. See more stats in GENCURIX INC. financial statements.
Like other stocks, 229000 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENCURIX INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENCURIX INC. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENCURIX INC. stock shows the neutral signal. See more of GENCURIX INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.